News Focus
News Focus
icon url

biomaven0

08/30/11 10:16 AM

#125894 RE: mcbio #125869

So if DM-1 gets approved end of 2012, then you are talking a couple of years of royalties only. And for Bapineuzumab the situation is even worse.

Peter